Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds
Year: 2023
Type: article
Abstract: Pentadecanoic acid (C15:0) is an essential odd-chain saturated fatty acid with broad activities relevant to protecting cardiometabolic, immune, and liver health. C15:0 activates AMPK and inhibits mTOR, both of which are core components of the human longevity pathway. To assess the potential for C15:0 to enhance processes associated with longevity and healthspan, we used human cell-based molecular phenotyping assays to compare C15:0 with three longevity-enhancing candidates: acarbose, metformin, and rapamycin. C15:0 (n = 36 activities in 10 of 12 cell systems) and rapamycin (n = 32 activities in 12 of 12 systems) had the most clinically relevant, dose-dependent activities. At their optimal doses, C15:0 (17 µM) and rapamycin (9 µM) shared 24 activities across 10 cell systems, including anti-inflammatory (e.g., lowered MCP-1, TNFα, IL-10, IL-17A/F), antifibrotic, and anticancer activities, which are further supported by previously published in vitro and in vivo studies. Paired with prior demonstrated abilities for C15:0 to target longevity pathways, hallmarks of aging, aging rate biomarkers, and core components of type 2 diabetes, heart disease, cancer, and nonalcoholic fatty liver disease, our results support C15:0 as an essential nutrient with activities equivalent to, or surpassing, leading longevity-enhancing candidate compounds.
Source: Nutrients
DOI: 10.3390/nu15214607
Authors: Stephanie Venn-Watson, Nicholas J. Schork
Language: English
Subfield: Aging
Domain: Life Sciences
Keywords: pentadecanoic acid, odd-chain saturated fatty acids, essential fatty acids, longevity, healthspan, AMPK activation, mTOR inhibition, rapamycin, metformin, acarbose, anti-inflammatory activity, antifibrotic activity, anticancer activity, aging biomarkers, cardiometabolic health, non-alcoholic fatty liver disease, type 2 diabetes
Open Access status: gold
Estimated APC paid: $2,892
OpenAlex ID: W4388017686
